Ad is loading...
KMSTF
Price
$6.40
Change
-$0.10 (-1.54%)
Updated
Mar 12 closing price
SRZN
Price
$10.60
Change
-$0.08 (-0.75%)
Updated
Dec 6, 04:59 PM (EDT)
Ad is loading...

KMSTF vs SRZN

Header iconKMSTF vs SRZN Comparison
Open Charts KMSTF vs SRZNBanner chart's image
KADIMASTEM
Price$6.40
Change-$0.10 (-1.54%)
Volume$100
CapitalizationN/A
Surrozen
Price$10.60
Change-$0.08 (-0.75%)
Volume$100
CapitalizationN/A
KMSTF vs SRZN Comparison Chart
Loading...
SRZN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KMSTF vs. SRZN commentary
Dec 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMSTF is a Buy and SRZN is a StrongSell.

COMPARISON
Comparison
Dec 07, 2024
Stock price -- (KMSTF: $6.40 vs. SRZN: $10.68)
Brand notoriety: KMSTF and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KMSTF: 100% vs. SRZN: 36%
Market capitalization -- KMSTF: $14.58M vs. SRZN: $34.71M
KMSTF [@Biotechnology] is valued at $14.58M. SRZN’s [@Biotechnology] market capitalization is $34.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMSTF’s FA Score shows that 0 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • KMSTF’s FA Score: 0 green, 5 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, KMSTF is a better buy in the long-term than SRZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRZN’s TA Score shows that 5 TA indicator(s) are bullish.

  • SRZN’s TA Score: 5 bullish, 5 bearish.

Price Growth

KMSTF (@Biotechnology) experienced а 0.00% price change this week, while SRZN (@Biotechnology) price change was +4.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.41%. For the same industry, the average monthly price growth was -1.11%, and the average quarterly price growth was +12.54%.

Reported Earning Dates

SRZN is expected to report earnings on Mar 21, 2024.

Industries' Descriptions

@Biotechnology (+0.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRZN($34.7M) has a higher market cap than KMSTF($14.6M). SRZN YTD gains are higher at: 13.617 vs. KMSTF (-1.477). KMSTF has higher annual earnings (EBITDA): -9.53M vs. SRZN (-25.06M). SRZN has higher revenues than KMSTF: SRZN (10M) vs KMSTF (0).
KMSTFSRZNKMSTF / SRZN
Capitalization14.6M34.7M42%
EBITDA-9.53M-25.06M38%
Gain YTD-1.47713.617-11%
P/E RatioN/AN/A-
Revenue010M-
Total CashN/A31M-
Total DebtN/A1.53M-
TECHNICAL ANALYSIS
Technical Analysis
KMSTFSRZN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
8%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
6%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
SRZN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YINN28.060.31
+1.12%
Direxion Daily FTSE China Bull 3X ETF
JIG66.730.13
+0.20%
JPMorgan International Growth ETF
INMU23.94N/A
+0.02%
iShares Intermediate Muni Income Act ETF
FXU40.07-0.01
-0.02%
First Trust Utilities AlphaDEX® ETF
SZK11.80-0.01
-0.09%
ProShares UltraShort Consumer Staples

KMSTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KMSTF has been loosely correlated with IRON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KMSTF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMSTF
1D Price
Change %
KMSTF100%
N/A
IRON - KMSTF
54%
Loosely correlated
-3.34%
ATBPF - KMSTF
52%
Loosely correlated
N/A
ZVRA - KMSTF
30%
Poorly correlated
-2.02%
ACUT - KMSTF
28%
Poorly correlated
N/A
SRZN - KMSTF
28%
Poorly correlated
-2.91%
More